The DNA methylome of benign and malignant parathyroid tumors

Genes Chromosomes and Cancer

Volumn 50, Issue 9, 2011, Pages 735-745

  Starker, Lee F ^a,c   Svedlund, Jessica ^c   Udelsman, Robert ^a   Dralle, Henning ^d   Åkerström, Göran ^c   Westin, Gunnar ^c   Lifton, Richard P ^a,b   Björklund, Peyman ^a,c   Carling, Tobias ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GENOMIC DNA; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 4; WT1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOMA; AZACITIDINE; CARCINOMA; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; PARATHYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 79960176508     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20895     Document Type: Article

References (32)

1. Arnold A, Kim HG. 1989. Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metab 69: 496-499.
2. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, Goldmann T, Seifart C, Jiang W, Barker DL, Chee MS, Floros J, Fan JB. 2006. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393.
3. Bjorklund P, Akerstrom G, Westin G. 2007. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. PLoS Med 4: e328.
4. Carling T, Åkerström G, Rastad J, Westin G. 1998. Vitamin D receptor (VDR) and parathyroid hormone mRNA levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 83: 2255-2259.
5. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akerstrom G, Melhus H. 1995. Vitamin D receptor genotypes in primary Hyperparathyroidism. Nat Med 1: 1309-1311.
6. Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, Trivedi S, Hellman P, Brown EM, Dahl N, Rastad J. 2000. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85: 2042-2047.
7. Carling T, Du Y, Fang W, Correa P, Huang S. 2003. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134: 932-939; discussion 939-940.
8. Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knuchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG. 2007. Frequent loss of SFRP1 expression in multiple human solid tumours: Association with aberrant promoter methylation in renal cell carcinoma. Oncogene 26: 5680-5691.
9. Fraker D. 2008. Parathyroid Tumors. In: DeVita V, Jr., Lawrence T, Rosenberg S, editors. Cancer: Principles & Practice of Oncology. 8th ed. Philadelphia: Lippincott-Raven, pp. 1690-1702.
10. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Speigel AM, Burns AL, Mark SJ. 1997. Somatic mutations of the MEN1 gene in parathyroid tumours. Nat Genet 16: 375-378.
11. Hopfer O, Komor M, Koehler IS, Freitag C, Schulze M, Hoelzer D, Thiel E, Hofmann WK. 2009. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms. Leuk Res 33: 434-442.
12. Hsi E, Zukerberg L, Yang W-I, Arnold A. 1996. Cyclin D1/PRAD1 expression in parathyroid adenomas: An immunohistochemical study. J Clin Endocrinol Metab 81: 1736-1739.
13. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB. 1997. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res 57: 1030-1034.
14. Jones PA, Baylin SB. 2007. The epigenomics of cancer. Cell 128: 683-692.
15. Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenstrom J, Hoog A, Larsson C. 2010. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS One 5: e9472.
16. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Yamada H, Yamamoto R, Sakuragi N, Enokida H, Verma M, Dahiya R. 2005. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer 104: 1924-1930.
17. Killian JK, Bilke S, Davis S, Walker RL, Killian MS, Jaeger EB, Chen Y, Hipp J, Pittaluga S, Raffeld M, Cornelison R, Smith WI Jr., Bibikova M, Fan JB, Emmert-Buck MR, Jaffe ES, Meltzer PS. 2009. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res 69: 758-764.
18. Kulis M, Esteller M. 2010. DNA methylation and cancer. Adv Genet 70: 27-56.
19. Lundgren E, Rastad J, Åkerström G, Ljunghall S. 1997. Population-based health screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121: 287-294.
20. Mosimann C, Hausmann G, Basler K. 2006. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 125: 327-341.
21. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515.
22. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K. 2010. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
23. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M. 2005. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25: 612-620.
24. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527.
25. Siilin H, Lundgren E, Mallmin H, Mellstrom D, Ohlsson C, Karlsson M, Orwoll E, Ljunggren O. 2011. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg.
26. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417-422.
27. Svedlund J, Auren M, Sundstrom M, Dralle H, Akerstrom G, Bjorklund P, Westin G. 2010. Aberrant WNT/beta-catenin signaling in parathyroid carcinoma. Mol Cancer 9: 294.
28. Tahara H, Smith A, Gaz R, Arnold A. 1996. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocr Metab 81: 3663-3667.
29. Thirlwell C, Eymard M, Feber A, Teschendorff A, Pearce K, Lechner M, Widschwendter M, Beck S. 2010. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52: 248-254.
30. Yi Y, Nowak NJ, Pacchia AL, Morrison C. 2008. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: Array CGH, FISH, and tissue microarrays. Genes Chromosomes Cancer 47: 639-648.
31. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD. 2003. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 13: 319-333.
32. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, Cui H. 2008. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206.